Posts By: Karen Jones

Do you ever shop online at Amazon?

    Then please do so by first going to www.omstc.org.uk (our website) and clicking on the amazon logo at the top of the page.  It really is that easy!   This raises about 5% of the money spent for OMSTC and does not cost you a penny! Right now we make roughly £30 a… Read more »

Photocopier urgently needed

Appeal for a photocopier for the centre, this one has died, it’s done well considering it was an ex-hired machine and we do not have a maintenance contract on it.  I’m not worried about size as long as it copies A4, preferably double sided.

“Diagnose and adios”. This was the phrase used to describe the management of multiple sclerosis (MS) up until the mid-1990s

Source MS Trust: The Risk Sharing Scheme: What is it and how has it made a difference for people with MS? Diagnose and adios “Diagnose and adios”. This was the phrase used to describe the management of multiple sclerosis (MS) up until the mid-1990s. It’s hard to fathom today, but back then neurologists had little to… Read more »

Get around with these apps for accessible travel

Source Independent Living: Travelling around the UK is certainly not easy for wheelchair users. Many wheelchair users have, in fact, faced prejudice while attempting to get around independently. Comedian, Tanyallee Davis, recently suffered and expressed her humiliation on a train journey during which the driver insisted she move from the disabled space she was rightfully occupying,… Read more »

Making a lasting power of attorney has never been easier!

Making a lasting power of attorney for your health and wellbeing and financial affairs has never been easier! You may never need it, but it’s a good idea to plan ahead just in case! The government online service will guide you through the process to create a lasting power of attorney. Find out more here.

Encouraging news for people with primary or secondary progressive MS

Source F1000 Prime: Fox et al. present the results of the eagerly awaited SPRINT-MS trial – a multi-centre phase II double blinded placebo controlled study of ibudilast in decreasing brain atrophy in progressive forms of multiple sclerosis (MS). Ibudilast was previously trialled in relapsing MS and whilst it did not prevent the reduction of new T2… Read more »